- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on IDH1-mutant Cholangiocarcinoma in New Zealand
Total 165 results
-
Weill Medical College of Cornell UniversityWithdrawnCholangiocarcinomaUnited States
-
Heinrich-Heine University, DuesseldorfServierCompleted
-
National Cancer Institute (NCI)RecruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Recurrent Gallbladder Carcinoma | Unresectable Gallbladder Carcinoma | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IV Distal Bile Duct Cancer... and other conditionsUnited States
-
TransThera Sciences (Nanjing), Inc.AvailableAdvanced Solid Tumors | CholangiocarcinomaUnited States
-
GenfitRecruitingCholangiocarcinomaUnited States, Puerto Rico
-
Criterium, Inc.University of Colorado, Denver; NovartisTerminatedPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Adenocarcinoma | Hepatocellular AdenocarcinomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Unresectable Extrahepatic... and other conditionsUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingAdvanced Solid Tumors | Cholangiocarcinoma | Urothelial CarcinomaAustralia, United States
-
Orbus Therapeutics, Inc.RecruitingGlioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, IDH-wildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeUnited States
-
Mauna Kea TechnologiesCompletedCholangiocarcinoma | Bile Duct InflammationUnited States, France, Italy
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | WHO Grade 3 Glioma | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Glioma | Recurrent Cholangiocarcinoma | WHO Grade 2 GliomaUnited States
-
New Mexico Cancer Care AllianceTerminatedHepatocellular Carcinoma | Bile Duct Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Extrahepatic Bile Duct Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Periampullary AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Gallbladder Carcinoma | Metastatic Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Metastatic Intrahepatic Cholangiocarcinoma | Recurrent Intrahepatic Cholangiocarcinoma | Metastatic... and other conditionsUnited States
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
Cheng-Chia (Fred) WuFocused Ultrasound FoundationActive, not recruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-MutantUnited States
-
PfizerMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd; Pierre Fabre MedicamentCompletedBRAF V600E-mutant Metastatic Colorectal CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Czechia, Taiwan, Belgium, France, Hungary, Canada, Japan, Russian Federation, Netherlands, Israel, Germany, Turkey, Austria, Brazil, Poland, Italy, Argentina, Chile, Denmar... and more
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Incyte CorporationCompletedCholangiocarcinomaUnited States, France, Italy, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Korea, Republic of, Japan, Thailand
-
Pierre Fabre MedicamentPfizer; Merck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdCompletedBRAF V600E-mutant Metastatic Colorectal CancerFrance, Italy, United States, Spain, United Kingdom, Belgium, Austria, Japan, Netherlands
-
Cheng-Chia (Fred) WuFocused Ultrasound FoundationActive, not recruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Pontine and Thalamic GliomasUnited States
-
Hackensack Meridian HealthCompletedPancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Liver CancerUnited States
-
Shuttle Pharmaceuticals, Inc.Not yet recruitingGlioblastoma, IDH-wildtypeUnited States
-
TransThera Sciences (Nanjing), Inc.RecruitingCholangiocarcinomaKorea, Republic of, United States, Spain, Taiwan, France, Belgium, Germany, Italy, Portugal, United Kingdom, Austria, Poland
-
Nataliya UbohaGilead Sciences; University of Wisconsin, Madison; Arcus Biosciences, Inc.RecruitingCholangiocarcinoma | Bile Duct Cancer | Biliary Tract CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingColorectal Cancer | CholangiocarcinomaUnited States
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
Weill Medical College of Cornell UniversityEMcision LimitedTerminatedPancreatic Cancer | CholangiocarcinomaUnited States
-
TransThera Sciences (Nanjing), Inc.CompletedCholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Fusion | FGFR1 Alteration | FGFR3 AlterationUnited States
-
Medical University of South CarolinaBoston University; Johns Hopkins University; Fox Chase Cancer Center; Washington... and other collaboratorsTerminatedCholangiocarcinoma | Hilar Lymphadenopathy | Biliary StrictureUnited States
-
Puma Biotechnology, Inc.CompletedHER2-mutant Non-Small Cell Lung CancerUnited States, France
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
Memorial Sloan Kettering Cancer CenterBayerCompletedGallbladder Cancer | Extrahepatic Bile Duct CancerUnited States
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Cholangiocarcinoma | Liver CancerUnited States
-
Lisata Therapeutics, Inc.RecruitingCholangiocarcinoma | Bile Duct Cancer | Intrahepatic Cholangiocarcinoma | Gallbladder Carcinoma | Gallbladder Cancer | Gall Bladder Cancer | Extrahepatic Cholangiocarcinoma | Gall Bladder CarcinomaUnited States, Spain
-
Leap Therapeutics, Inc.CompletedCholangiocarcinoma | Bile Duct Cancer | Carcinoma of Intrahepatic and Extra-hepatic Biliary System | Carcinoma of GallbladderUnited States
-
Weill Medical College of Cornell UniversityUnknownCholangiocarcinoma | Bile Duct Cancer | Biliary Stricture | Biliary ObstructionUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBile Duct Cancer | Liver Cancer | Gallbladder CancerUnited States
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Glioblastoma, Not Otherwise SpecifiedUnited States, Australia, New Zealand, Canada
-
Roswell Park Cancer InstituteCompletedGallbladder Cancer | Extrahepatic Bile Duct CancerUnited States
-
SOFIERecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Gastrointestinal CancersUnited States
-
Eli Lilly and CompanyCompletedSoft Tissue Sarcoma | Breast Cancer | Solid Tumor | Cholangiocarcinoma | Colon CancerUnited States, France, Spain, Denmark
-
Roswell Park Cancer InstituteCelgeneWithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Blasts Under 5 Percent of Peripheral Blood White Cells | Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment LevelUnited States
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaNetherlands, Korea, Republic of, Spain, Taiwan, Japan, Italy, United States, Singapore, Canada
-
SirnaomicsTranslational Drug DevelopmentCompletedHepatocellular Carcinoma | Cholangiocarcinoma | Liver MetastasesUnited States
-
Calithera Biosciences, IncCompletedRenal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditionsUnited States
-
Boehringer IngelheimCompletedGastrointestinal Neoplasms | Pancreatic Neoplasms | CholangiocarcinomaSpain, Belgium, China, United States, Germany, Korea, Republic of, France, Japan
-
CelgeneCelgene CorporationCompletedGlioma | Solid Tumor | Angioimmunoblastic T-cell Lymphoma | Chondrosarcoma | Intrahepatic CholangiocarcinomaUnited States, France
-
Compass TherapeuticsRecruitingCholangiocarcinoma | Biliary Tract Cancer | Gall Bladder Cancer | Ampullary CancerUnited States
-
Debiopharm International SARecruitingAstrocytoma, Grade III | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeSpain, United States, Switzerland
-
Northwell HealthRecruitingGlioblastoma | Brain Cancer | Glioblastoma Multiforme | GBM | Glioma, Malignant | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, AdultUnited States